Home
›
Reviva Pharmaceuticals Holdings, Inc.
› SCHEDULE 13D/A Jan 31, 2025
Reviva Pharmaceuticals Holdings, Inc. (RVPH): SCHEDULE 13D/A filed Jan 31, 2025
Form type
SCHEDULE 13D/A
Filing date
Jan 31, 2025
Accession number
0001493152-25-004530
Filer
Reviva Pharmaceuticals Holdings, Inc.
(CIK 1742927)